Pfizer (PFE) Appoints Chris Boshoff as Chief Oncology Research and Development Officer
Company
Pfizer
New YorkBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharmapharmaceuticalsDescription
Effective today, Chris Boshoff, M.D., PhD, will join Pfizer’s Executive Leadership Team as Chief Oncology Research and Development Officer and Executive Vice President reporting to Chairman and Chief Executive Officer, Albert Bourla. Under his leadership, Pfizer will continue to invest in its fight against cancer and Dr. Boshoff will be the single point of accountability for the entire oncology pipeline – from discovery to early and late-phase clinical development. Mikael Dolsten, M.D., PhD, currently Chief Scientific Officer & President, Pfizer Worldwide Research, Development and Medical, will now expand his role to lead all discovery, early- and late-stage clinical development, for all non-oncology therapeutic areas as Chief Scientific Officer, President, Pfizer Research & Development
Quick answer
Pfizer (PFE) Appoints Chris Boshoff as Chief Oncology Research and Development Officer (July 27, 2023). Pfizer is based in New York, New York, United States.
- What did Pfizer announce on July 27, 2023?
- Effective today, Chris Boshoff, M.D., PhD, will join Pfizer’s Executive Leadership Team as Chief Oncology Research and Development Officer and Executive Vice President reporting to Chairman and Chief Executive Officer, Albert Bourla. Under his leadership, Pfizer will continue to invest in its fight against cancer and Dr. Boshoff will be the single point of accountability for the entire oncology pipeline – from...
- Where is Pfizer based?
- Pfizer is based in New York, New York, United States.
- Which similar companies made leadership changes around the same time?
- Acadia Pharmaceuticals (July 25, 2023), LumaBridge (August 8, 2023), Arbutus (July 11, 2023) and MBX Biosciences, Inc. (July 10, 2023) also announced leadership changes within 45 days of Pfizer.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Pharmaceutical
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Acadia Pharmaceuticals Appoints Kevin Oliver Chief Business Officer (July 25, 2023)
- Amanda Ferrier Joins LumaBridge as Chief Operating Officer (August 8, 2023)
- Arbutus Biopharma appoints Karen Sims as chief medical officer (NASDAQ:ABUS) | Seeking Alpha (July 11, 2023)
- MBX Biosciences Appoints Steven J. Prestrelski, Ph.D., (July 10, 2023)
- Vistagen Appoints Cindy Anderson as Chief Financial Officer (August 22, 2023)
- AbbVie Inc Appoints Robert A Michael as President and Chief Operating Officer Demonstrating Commitment to Strong Leadership and Continued Growth - Best Stocks (June 29, 2023)
Who to call at Pfizer, and when
A new leader at Pfizer brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Pfizer raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Pfizer, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Pfizer. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Pfizer changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Pfizer changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.